20 ML mirvetuximab soravtansine-gynx 5 MG/ML Injection [Elahere]
RxNorm concept 2621559, branded drug (sbd). Prescribable name: ELAHERE 100 MG in 20 ML Injection.
- RxCUI
- 2621559
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2621559 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Elahere 100 MG per 20 ML Injection; Elahere 5 MG/ML per 20 ML Injection
Related concepts
- mirvetuximab soravtansine-gynx 5 MG/ML (SCDC, consists of)
- mirvetuximab soravtansine-gynx 5 MG/ML [Elahere] (SBDC, consists of)
- Injection (DF, has dose form)
- Elahere (BN, has ingredient)
- 20 ML mirvetuximab soravtansine-gynx 5 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2621559 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2621559 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2621559. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.